Poliovirus-binding inhibition ELISA for evaluation of immune response to oral poliovirus vaccine: a possible alternative to the neutralization test

Hum Vaccin. 2005 May-Jun;1(3):102-5. doi: 10.4161/hv.1.3.1719. Epub 2005 May 5.

Abstract

This study describes an ELISA variant (Binding Inhibition ELISA, BI ELISA) for the quantitative determination of neutralization-relevant antibodies to polioviruses. The test differs from previously described analogs by utilizing polyclonal immune reagents: capture antibodies and biotin-labeled detecting antibodies. The BI ELISA was compared with the conventional neutralization test (NT) by testing live Sabin and wild-type poliovirus strains. The comparison of 68 serum samples taken from Oral Poliovirus Vaccine (OPV) recipients showed 100% specificity and sensitivity for Sabin 1 and Sabin 2, and 100% sensitivity and 97% specificity for Sabin 3. Good correlations (r = 0.7, 0.77, 0.65 for Sabin 1, 2, 3, respectively) were demonstrated between the NT and BI ELISA results. These results indicate that the BI ELISA can be used as a reliable alternative to the NT for determination of neutralization-relevant antibodies to polioviruses in vaccinees and in large-scale sero-epidemiological studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral / analysis
  • Antibodies, Viral / biosynthesis*
  • Antigens, Viral / analysis
  • Biotin / chemistry
  • Child
  • Cross Reactions
  • Enzyme-Linked Immunosorbent Assay / methods*
  • Female
  • Humans
  • Immune Sera / chemistry
  • Immune Sera / immunology
  • Immunoglobulin G / immunology
  • Indicators and Reagents
  • Male
  • Neutralization Tests
  • Poliovirus / immunology*
  • Poliovirus / metabolism*
  • Poliovirus Vaccine, Oral / immunology*
  • Rabbits

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • Immune Sera
  • Immunoglobulin G
  • Indicators and Reagents
  • Poliovirus Vaccine, Oral
  • Biotin